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Let’s imagine the cruise control of your car locked at 120 km/h on any road in any condition
(city, country, highway, sunny or rainy weather), or your car air conditioner set on maximum
cold in any temperature condition (even during a snowy winter): would you find it efficient?
That would probably not be the most optimal strategy for a proper and comfortable driving
experience. As surprising as this may seem, this is a pretty accurate illustration of how
deep brain stimulation is used today to treat Parkinson’s disease motor symptoms and
other neurological disorders such as essential tremor, obsessive-compulsive disorder, or
epilepsy.
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In Parkinson’s disease, DBS is a neurosurgical treatment offered
to approximately 5% of patients, and consists in the permanent
implantation of stimulating electrodes in deep brain structures
(in most cases, the subthalamic nucleus). These electrodes are
connected to a pacemaker and deliver electrical impulses at high
frequency (typically, 130–180 Hz) 24/7. This treatment drastically
relieves tremor, rigidity, and akinesia in most patients. However,
DBS sometimes induces adverse effects (e.g., weight gain). Surpris-
ingly, while DBS works well, physiological mechanisms underlying
DBS benefits in patients are not known to-date, which constitutes
a major drawback.
However, things will change in the near future. Numerous bio-
markers (biological indicators of specific physiological or patho-
logical processes, e.g., selected frequency components of brain
electrical activity) have been used recently to investigate DBS
impact throughout a wide range of brain regions and functions
(see Phillips et al., 2006; Bronte-Stewart et al., 2009; Rosa et al.,
2010). Although a unified view of DBS impact on brain activity
still has to be reached, it is tempting to use such biomarkers as
indicators to regulate and optimize “online” the stimulation sig-
nal. In other words, monitoring these biomarkers could help to
improve DBS by adding a “thermostat” that would “regulate the
brain activity” using appropriate stimulation in a smarter way:
the brain “temperature” would be monitored and “regulated” only
when needed (using relevant biomarkers), and as needed (using
relevant stimulation signal). This strategy is termed “closed-loop”
stimulation, as opposed to current “open-loop” DBS strategy, i.e.,
the stimulation signal is fixed over time.
Over the recent years, several research groups have attempted
to develop closed-loop neurostimulation methods for Parkinson’s
disease, but they are mainly theoretical and essentially exist in sil-
ico (in computer models) today (Schiff and Sauer, 2008; Modolo
et al., 2010). Indeed, innovative closed-loop therapeutics have
been mostly developed based on biophysical brain activity models,
using mathematical equations describing and predicting neural
networks activity. Such models offer a predictive capacity needed
to evaluate the brain response under a closed-loop stimulation sig-
nal. The common rationale between these closed-loop strategies is
to provide a stimulation targeting specific brain areas, to attenuate
and control pathological brain rhythms based on instantaneous
brain activity recordings. Since these techniques are mainly based
on biophysical models rather than animal models, thus involving
major simplifications of the real living brain, they understand-
ably give rise to skepticism from the medical community. As a
consequence, clinical translation has been limited to-date.
Nevertheless, several groups are developing various techniques
aiming“on-demand”brain stimulation techniques. As an example,
experimental setups allowing the monitoring of neurotransmitters
(e.g., dopamine) during DBS have been developed, intending to
evaluate the best moment to deliver electrical stimulation (Roham
et al., 2009). The idea that neuromimetic chipsets could be appro-
priate to provide physiologically relevant stimulation has also been
proposed (see the Renachip project, http://www.renachip.org).
Furthermore, closed-loop stimulation is already used for car-
diac stimulation and implemented in commercial devices (e.g.,
Medtronic Sensia), with electrical stimulation being delivered as
a function of the heart rate. Therefore, closed-loop neurostimula-
tion is no longer a dream,but is it just about translating closed-loop
technology from cardiology to neurology? Not only: we think that
biophysical models have also their word to say, and that they will
accelerate the process. An elegant example is the successful con-
trol of neuronal activity by electric stimulation at times predicted
by chaos theory (Schiff et al., 1994). This work has provided the
“proof of concept” that closed-loop neuromodulation is not only
technically feasible, but also that models can assist in this process.
Importantly, significant advances in neuroengineering suggest that
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advanced closed-loop techniques might be available for patients
sooner than expected. Indeed, Viventi et al. (2011) have recently
proposed a high-density matrix of electrodes flexible enough to
adapt to specific gyri and sulci geometry. Such high-resolution
spatiotemporal cortical activity mappings, with the capability to
record neural signals but also to provide electrical stimulation,
represents an extraordinary perspective of new-generation med-
ical devices, of course if, and only if, it is programmed with a
“smart” stimulation algorithm. Importantly, encouraging exper-
imental evidence has been provided in a recent study (Rosin
et al., 2011) investigating the effects of closed-loop DBS in MPTP
monkeys (PD animal model, involving the intake of 1-methyl-4-
phenyl-1,2,3,6-tetrahydropyridine – MPTP, destroying dopamin-
ergic neurons and thus mimicking neurodegenerative processes
taking place in PD). Indeed, based on stimulation of the GPi (inter-
nal segment of the globus pallidus) using a pulse train following
spikes detection in GPi or M1 (primary motor cortex), the authors
were able to demonstrate an improvement of symptoms (e.g., aki-
nesia). Consequently, there is a convergence of not only theoretical,
but also experimental evidence pointing at the use of closed-loop
neurostimulation devices in the very near future for the benefit of
patients.
Several biophysical models have provided clinically relevant
descriptions of in vivo human brain activity. For example, neural
mass models, consisting of integro-differential equations, accu-
rately describe cortical activity using large assemblies of neurons
interconnected with specific types of synapses and associated
kinetics. These models have been successful in understanding
epileptic onset in humans, and have provided fruitful insights into
underlying disease mechanisms (Wendling et al., 2002). Remark-
ably, they have also been used to successfully describe and predict
the occurrence of visual hallucination patterns (Ermentrout and
Cowan, 1979), electroencephalographic dynamics activity and its
changes during general anesthesia (Hutt, 2011). Since neural mass
models are used to describe naturally occurring physiological
and pathological phenomena, they are an attractive tool to assist
in the conception of closed-loop innovative therapeutic strate-
gies. Thus, in neuroscience and not only in physics; mathematics
have an almost insolent success, and we can ask with Albert Ein-
stein (1921, in a lecture to the Prussian Academy of Science in
Berlin): “How can it be that mathematics, being after all a prod-
uct of human thought which is independent of experience, is
so admirably appropriate to the objects of reality?” Furthermore,
there is increased awareness about the role of dynamical systems
theory in our understanding of brain function, as it is emphasized
in a recent paper (Potter, 2011): “Perhaps, we are only beginning
to appreciate the complexity and dynamics of the neural circuits
involved.” Overall, compared to initial models investigating the
possibility of closed-loop stimulation in Parkinson’s disease, the
use of neural mass and neural field models represents a signif-
icant advance in providing biologically relevant description of
brain tissue dynamics. By their capacity to simulate electric (elec-
troencephalography) and metabolic (e.g., oxygen consumption
as measured by functional magnetic resonance imaging) brain
activity, these models bring us closer to meaningful compar-
isons and validations with experimental data recorded in human
patients.
Acknowledging the usefulness of brain activity biophysical
models in new therapeutic applications development does not
mean abandoning animal or human testing. Indeed, in a solid
biologically grounded biophysical model, electrical stimulations
like those produced by DBS (e.g., in Parkinson’s disease), can be
simulated and integrated to the system of equations. For exam-
ple, model-based clinical tools have been developed and are used
today, in order to optimize DBS parameters to individual patient
anatomy and response to stimulation. Such models based on a
detailed biophysical description of the interaction between the
electric field induced by DBS and the response at the level of
nerve fibers make it possible to bridge biophysical models with
predictable clinical outcomes (Maks et al., 2009; McIntyre et al.,
2011). It becomes then possible to monitor its impact on specific
biologically significant outcomes of the model: modulations in the
outcomes are indicative of changes in specific physiological para-
meters (e.g., characterizing neuronal connections architecture).
Model results can thus be confronted to experimental results to
support existing, or propose new, hypotheses in terms of mecha-
nisms involved. This illustrates how biologically based biophysical
brain activity models, such as neural mass models, can improve
human data understanding, and should be viewed as a required
tool that conveniently and efficiently complements experimental
neurostimulation research limitations. In our view, the use of bio-
physical models will be mandatory to further understand brain
activity and to conceive the next-generation of closed-loop neu-
rostimulation devices. Indeed, before talking to the brain, we first
have to understand the language it speaks.
A closed-loop neurostimulation therapy, optimized and widely
available for patients, is only steps away. It is most likely that bio-
physical models of brain activity will play a critical role to end
this journey: they will help us to escape from current neurostim-
ulation techniques based on random, empirical observations; to
propose individualized, smart, and less invasive neuromodulation
technologies.
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